CURRICULUM VITAE
Name: Mark
S. Schlissel
Birth: November
24, 1957
Brooklyn,
New York
Address: 26
Merrill Circle South
Moraga,
CA, 94556
Phone: 510-643-2462
(lab)
EMPLOYMENT
College of Letters & Science
Director,
Berkeley Health Sciences Initiative
Professor of Biochemistry & Molecular Biology
Vice-Chair (2002-2007)
Shubert Family Assoc. Professor of Biochemistry
& Associate Professor of Immunology
(1999-2002)
Department
of Molecular and Cell Biology
University
of California, Berkeley
Associate Professor (1995-1999)
Assistant
Professor (1991-1995)
Department
of Medicine
Department
of Molecular Biology and Genetics
Department
of Oncology
The
Johns Hopkins University
School
of Medicine
EDUCATION
Undergraduate: Bachelor
of Arts, 1979
Princeton
University
Major
in Biochemical Sciences
Graduate: M.D.
and Ph.D. (Physiological Chemistry), 1986
Johns
Hopkins University
Thesis
Advisor-- Dr. Donald D. Brown
Postgraduate: Medical
Residency, 1986-1988
The
Johns Hopkins Hospital
Postdoctoral
Research Fellow, 1988-1991
Whitehead
Institute for Biological Research
Research
Advisor-- Dr. David Baltimore
HONORS AND AWARDS
Undergraduate: A.B.,
Summa cum laude
Elected,
Phi Beta Kappa
Elected,
Sigma Xi Science Honor Society
Graduate: Fellow:
NIH Medical Scientist Training Program,
1979-1986
Recipient:
Michael A. Shanoff Research
Award, 1984
Postgraduate: Awardee: Bristol-Myers Cancer Research
Fellowship, 1988-1991
Diplomate: American Board of Internal
Medicine
Faculty: Cancer
Research Institute Investigator Award, 1992
Culpeper
Foundation Scholar, 1993
Leukemia
Society Scholar, 1996-2001
W.W.
Smith Foundation Scholar, 1997
Associate
Editor, Journal of Immunology
(1995-1998)
Elected
to Membership, American Society
for
Clinical Investigation (1998)
Graduate
Student Teaching Award (1998)
NIH
Immunobiology (IMB). Study Section (2000-2002 member,
2002-2004 Chair)
Stohlman Scholar, Leukemia & Lymphoma Society (2001)
NIH
MERIT Award (2005-2015)
AD HOC REVIEWER
Cell Immunity
Science Molecular
Cell
Nature Journal
of Immunology
J.
Exp. Medicine Molecular
& Cell Biology
Nucleic Acids Res. International
Immunology
Embo Journal Nature
Immunology
Nature
Genetics Oncogene
Blood PLOS
INSTITUTIONAL RESPONSIBILITIES
Teaching-- MCB 150, Molecular Immunology. (2000-2003, 2008 teaching
evaluation 6.72 / 7.0).
MCB 250, Graduate Immunology. (2000, 2004; teaching evaluation
6.58 / 7.0).
MCB
251, Regulation of Immune System Development and
Function. (2000-present).
Bio1A Introductory
Biology (2006- present ; teaching evaluation 5.9/7.0)
Administrative--
Graduate
Admissions Committee 1999-2001; (co-chair
2000, chair 2001).
Graduate Affairs Committee (2000-2002).
MCB
Departmental Graduate Diversity Officer (1999-2003).
Faculty
Search Committee (Immunology; 2000-2001)
Vice-Chair,
Molecular & Cell Biology (2002 to 2007)
Dean
of Biological Sciences (2008-present)
OUTSIDE ORGANIZATION RESPONSIBILITIES
American Association of Immunologists (AAI) Education
Committee (2000-2003)
Midwinter
Conference of Immunologists Organizing Committee (2001-2006)
Scientific
Advisory Board-- Genetastix, Inc. (2000-2006)
Scientific
Advisor—Leukemia & Lymphoma Society (2001-2003)
Chair—Immunobiology Study Section (NIH) (2002-2004)
HHMI
Board of Scientific Advisors (2005-present)
Organizer,
Cold Spring Harbor Meeting ÒSignaling and Transcription in the Immune
system (2008, 2010)
Organizer,
Keystone Meeting, B Cells in Health and Disease (2009)
Expert
Witness—Biogen Idec (Patent infringement case;
2006-2007)
INVITED LECTURES (2000-present)
UCSF Keystone
Symposium
University
of Illinois Med. FASEB
Meeting
University
of Pennsylvania Gordon
Conference
Emory AAI
Meeting
University
of Chicago Stanford
University
University
of Washington Harvard
Medical School
University
of Kentucky Fox
Chase Cancer Center
University
of Virginia Ohio
State University
Duke
University Cold
Spring Harbor Meetings (2004, 2006)
University of Calif. Irvine Scripps
Research Inst.
Aegean
Conference National
Jewish Hospital
UCLA NYU
Medical School
RCAI
Symp (Yokohama) Tufts
Medical School
Yale Johns
Hopkins Medical
USC Erlangen
Symposium (Germany)
Columbia
P&S University
of Pittsburg
Washington
Univ University
of Pennsylvania
University of Toronto La
Jolla Inst. Of Allergy & Immunology
University
of Alabama University of Vermont
University
of Massachusetts
GRANT SUPPORT
NIH HL48702-16 The
Regulation of B Cell Development.
NIH
AI 57487-05 c-Abl
in B Cell Development and Leukemia
PUBLICATIONS
(peer reviewed
article numbers in boldface)
1. Cozzarelli, N.R., S.P. Gerrard,
M. Schlissel, D.D. Brown, and D.F. Bogenhagen. 1983. Purified RNA polymerase III accurately
and efficiently terminates transcription of 5S RNA genes. Cell
34:829-835.
2. Wormington, W.M., M. Schlissel,
and D.D. Brown. 1983. Developmental regulation of Xenopus 5S RNA genes. Cold
Spring Harb Symp Quant Biol
47:879-884.
3. Schlissel, M.S., and D.D. Brown. 1984.
The transcriptional regulation of Xenopus 5s RNA genes in chromatin: the roles
of active stable transcription complexes and histone H1. Cell
37:903-913.
4. Brown,
D.D., and M.S. Schlissel. 1985. The
molecular basis of differential gene expression of two 5S RNA genes. Cold
Spring Harb Symp Quant Biol
50:549-553.
5. Brown,
D.D., and M.S. Schlissel. 1985. A
positive transcription factor controls the differential expression of two 5S
RNA genes. Cell 42:759-767.
6. Schlissel, M.S., and D. Baltimore.
1989. Activation of immunoglobulin kappa gene rearrangement correlates with
induction of germline kappa gene transcription. Cell
58:1001-1007.
7. Hendrickson,
E.A., M.S. Schlissel, and D.T.
Weaver. 1990. Wild-type V(D)J recombination in scid
pre-B cells. Mol Cell Biol
10:5397-5407.
8. Schlissel, M., A. Voronova, and D.
Baltimore. 1991. Helix-loop-helix transcription factor E47 activates germ-line
immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T-cell
line. Genes Dev
5:1367-1376.
9. Schlissel, M.S., L.M. Corcoran, and D.
Baltimore. 1991. Virus-transformed pre-B cells show ordered activation but not
inactivation of immunoglobulin gene rearrangement and transcription. J
Exp Med 173:711-720.
10. Morrow,
T., and M. Schlissel. 1992. The
purification of B-cell precursors from mouse fetal liver. Curr
Top Microbiol Immunol
182:55-64.
11. Schatz,
D.G., M.A. Oettinger, and M.S. Schlissel.
1992. V(D)J recombination: molecular biology and
regulation. Annu
Rev Immunol 10:359-383.
12. Schlissel, M., A. Constantinescu, T.
Morrow, M. Baxter, and A. Peng. 1993. Double-strand signal sequence breaks in V(D)J recombination are blunt, 5'-phosphorylated,
RAG-dependent, and cell cycle regulated. Genes Dev
7:2520-2532.
13. Shapiro,
A.M., M.S. Schlissel, D. Baltimore,
and A.L. DeFranco. 1993. Stimulation of kappa light-chain gene rearrangement by
the immunoglobulin mu heavy chain in a pre-B-cell line. Mol
Cell Biol 13:5679-5690.
14. Bain, G.,
E.C. Maandag, D.J. Izon, D. Amsen, A.M. Kruisbeek, B.C. Weintraub, I. Krop,
M.S. Schlissel, A.J. Feeney, M. van
Roon, and et al. 1994. E2A proteins are required for proper B cell development
and initiation of immunoglobulin gene rearrangements [see comments]. Cell
79:885-892.
15. Schlissel, M.S., and T. Morrow. 1994.
Ig heavy chain protein controls B cell development by regulating germ- line
transcription and retargeting V(D)J recombination. J
Immunol 153:1645-1657.
16. Spanopoulou,
E., C.A. Roman, L.M. Corcoran, M.S. Schlissel,
D.P. Silver, D. Nemazee, M.C. Nussenzweig, S.A. Shinton, R.R. Hardy, and D.
Baltimore. 1994. Functional immunoglobulin transgenes guide ordered B-cell
differentiation in Rag-1-deficient mice. Genes Dev
8:1030-1042.
17. Schlissel, M., and T. Morrow. 1995.
Broken-ended DNA and V(D)J recombination. Curr
Top Microbiol Immunol
194:381-388.
18. Casciola-Rosen,
L., A. Rosen, M. Petri, and M. Schlissel.
1996. Surface blebs on apoptotic cells are sites of enhanced procoagulant
activity: implications for coagulation events and antigenic spread in systemic
lupus erythematosus. Proc Natl Acad Sci U S A 93:1624-1629.
19. Fang, W.,
D.L. Mueller, C.A. Pennell, J.J. Rivard, Y.S. Li,
R.R. Hardy, M.S. Schlissel, and T.W.
Behrens. 1996. Frequent aberrant immunoglobulin gene rearrangements in pro-B
cells revealed by a bcl-xL transgene. Immunity
4:291-299.
20. Krop, I.,
A.R. de Fougerolles, R.R. Hardy, M. Allison, M.S. Schlissel, and D.T. Fearon. 1996. Self-renewal of B-1 lymphocytes
is dependent on CD19. Eur J Immunol
26:238-242.
21. Krop, I.,
A.L. Shaffer, D.T. Fearon, and M.S. Schlissel.
1996. The signaling activity of murine CD19 is regulated during cell development.
J Immunol 157:48-56.
22. Nacht, M., A. Strasser, Y.R. Chan, A.W. Harris, M. Schlissel, R.T. Bronson, and T. Jacks.
1996. Mutations in the p53 and SCID genes cooperate in tumorigenesis.
Genes Dev 10:2055-2066.
23. Stanhope-Baker,
P., K.M. Hudson, A.L. Shaffer, A. Constantinescu, and M.S. Schlissel. 1996. Cell type-specific chromatin structure determines
the targeting of V(D)J recombinase activity in vitro. Cell
85:887-897.
24. Bain, G.,
E.C. Robanus Maandag, H.P. te Riele, A.J. Feeney, A.
Sheehy, M. Schlissel, S.A. Shinton,
R.R. Hardy, and C. Murre. 1997. Both E12 and E47 allow commitment to the B cell
lineage. Immunity
6:145-154.
25. Constantinescu,
A., and M.S. Schlissel. 1997.
Changes in locus-specific V(D)J recombinase activity
induced by immunoglobulin gene products during B cell development. J
Exp Med 185:609-620.
26. Gu, Y.,
K.J. Seidl, G.A. Rathbun, C. Zhu, J.P. Manis, N. van der Stoep, L. Davidson, H.L. Cheng, J.M. Sekiguchi, K. Frank, P. Stanhope-Baker, M.S. Schlissel, D.B. Roth, and F.W. Alt.
1997. Growth retardation and leaky SCID phenotype of
Ku70-deficient mice. Immunity
7:653-665.
27. Han, S.,
S.R. Dillon, B. Zheng, M. Shimoda,
M.S. Schlissel, and G. Kelsoe. 1997.
V(D)J recombinase activity in a subset of germinal
center B lymphocytes [see comments]. Science
278:301-305.
28. Schlissel, M.S., and P. Stanhope-Baker.
1997. Accessibility and the developmental regulation of V(D)J
recombination. Semin
Immunol 9:161-170.
29. Shaffer,
A.L., A. Peng, and M.S. Schlissel.
1997. In vivo occupancy of the kappa light chain enhancers in primary pro- and
pre-B cells: a model for kappa locus activation. Immunity
6:131-143.
30. Shaffer,
A.L., and M.S. Schlissel. 1997. A
truncated heavy chain protein relieves the requirement for surrogate light
chains in early B cell development. J Immunol
159:1265-1275.
31. Hempel, W.M., P. Stanhope-Baker, N. Mathieu, F. Huang, M.S.
Schlissel, and P. Ferrier. 1998.
Enhancer control of V(D)J recombination at the TCRbeta locus: differential effects on DNA cleavage and
joining. Genes Dev
12:2305-2317.
32. Schlissel, M.S. 1998. Structure of nonhairpin coding-end DNA breaks in cells undergoing V(D)J recombination. Mol Cell Biol
18:2029-2037.
33. Golding,
A., S. Chandler, E. Ballestar, A.P. Wolffe, and M.S. Schlissel.
1999. Nucleosome structure completely inhibits in vitro cleavage by the V(D)J recombinase. Embo
J 18:3712-3723.
34. Lauring, J., and M.S. Schlissel.
1999. Distinct factors regulate the murine RAG-2 promoter in B- and T-cell
lines. Mol Cell Biol
19:2601-2612.
35. Morrow,
T.A., S.A. Muljo, J. Zhang, J.M. Hardwick, and M.S. Schlissel. 1999. Pro-B-cell-specific
transcription and proapoptotic function of protein
kinase ceta. Cell
Biol 19:5608-5618.
36. Sheehy,
A.M., and M.S. Schlissel. 1999.
Overexpression of RelA causes G1 arrest and apoptosis in a pro-B cell line. J
Biol Chem 274:8708-8716.
37. Dillon,
S.R., M. Mancini, A. Rosen, and M.S. Schlissel.
2000. Annexin V binds to viable B cells and colocalizes
with a marker of lipid rafts upon B cell receptor activation. J
Immunol 164:1322-1332.
38. Muljo, S.A., and M.S. Schlissel.
2000. Pre-B and pre-T-cell receptors: conservation of strategies in regulating
early lymphocyte development. Immunol
Rev 175:80-93.
39. Schlissel, M.S. 2000. Perspectives:
transcription. A tail of histone acetylation and DNA
recombination. Science
287:438-440.
40. Schlissel, M.S., S.D. Durum, and K.
Muegge. 2000. The interleukin 7 receptor is required for T cell receptor gamma
locus accessibility to the V(D)J recombinase. J
Exp Med 191:1045-1050.
41. Wang, Q.F.,
J. Lauring, and M.S. Schlissel. 2000. c-Myb
binds to a sequence in the proximal region of the RAG-2 promoter and is
essential for promoter activity in T-lineage cells. Mol
Cell Biol 20:9203-9211.
42. Whitehurst,
C.E., M.S. Schlissel, and J. Chen. 2000.
Deletion of germline promoter PD beta 1 from the TCR beta locus causes hypermethylation that impairs D beta 1 recombination by
multiple mechanisms. Immunity
13:703-714.
43. Cost,
G.J., A. Golding, M.S. Schlissel,
and J.D. Boeke. 2001. Target DNA chromatinization
modulates nicking by L1 endonuclease. Nucleic Acids
Res 29:573-577.
44. Dillon,
S.R., A. Constantinescu, and M.S. Schlissel.
2001. Annexin V binds to positively selected B cells. J
Immunol 166:58-71.
45. Lee, P.P.,
D.R. Fitzpatrick, C. Beard, H.K. Jessup, S. Lehar, K.W. Makar,
M. Perez-Melgosa, M.T. Sweetser,
M.S. Schlissel, S. Nguyen, S.R.
Cherry, J.H. Tsai, S.M. Tucker, W.M. Weaver, A. Kelso, R. Jaenisch,
and C.B. Wilson. 2001. A critical role for dnmt1 and DNA methylation in T cell
development, function, and survival. Immunity
15:763-774.
46. Lu, L.,
C.A. Bonham, X. Liang, Z. Chen, W. Li, L. Wang, S.C. Watkins, M.A. Nalesnik, M.S. Schlissel,
A.J. Demestris, J.J. Fung, and S. Qian.
2001. Liver-derived DEC205+B220+CD19- dendritic cells regulate T cell
responses. J Immunol
166:7042-7052.
48. Dillon,
S.R., and M.S. Schlissel. 2002.
Partial restoration of B cell development in Jak-3(-/-)
mice achieved by co-expression of IgH and E(mu)-myc transgenes. Int
Immunol 14:893-904.
49. Goldmit, M., M. Schlissel,
H. Cedar, and Y. Bergman. 2002. Differential accessibility at the kappa chain
locus plays a role in allelic exclusion. Embo
J 21:5255-5261.
50. Liang,
H.E., L.Y. Hsu, D. Cado, L.G. Cowell,
G. Kelsoe, and M.S. Schlissel. 2002.
The "dispensable" portion of RAG2 is necessary for efficient V-to-DJ
rearrangement during B and T cell development. Immunity
17:639-651.
51. Muljo, S.A., and M.S. Schlissel.
2002. The variable, C(H)1, C(H)2 and C(H)3 domains of
Ig heavy chain are dispensable for pre-BCR function in transgenic mice. Int
Immunol 14:577-584.
52. Schlissel, M. 2002. Allelic exclusion
of immunoglobulin gene rearrangement and expression: why and how? Semin
Immunol 14:207.
53. Schlissel, M.S. 2002. Does artemis end the hunt for the hairpin-opening activity in V(D)J recombination? Cell
109:1-4.
54. Hsu, L.Y.,
J. Lauring, H.E. Liang, S. Greenbaum,
D. Cado, Y. Zhuang, and M.S. Schlissel. 2003. A conserved transcriptional enhancer regulates RAG
gene expression in developing B cells. Immunity
19:105-117.
55. Muljo, S.A., and M.S. Schlissel.
2003. A small molecule Abl kinase inhibitor induces differentiation of Abelson
virus-transformed pre-B cell lines. Nat
Immunol 4:31-37.
56. Robey, E., and M. Schlissel. 2003. Lymphocyte
development. Curr Opin Immunol
15:155-157.
57. Schlissel, M. 2003. How pre-B cells
know when they have it right. Nat Immunol
4:817-819.
58. Schlissel, M.S. 2003. Regulating
antigen-receptor gene assembly. Nat Rev Immunol
3:890-899.
59. Borghesi, L., L.Y. Hsu, J.P. Miller, M. Anderson, L. Herzenberg, M.S. Schlissel,
D. Allman, and R.M. Gerstein. 2004. B
lineage-specific regulation of V(D)J recombinase
activity is established in common lymphoid progenitors. J
Exp Med 199:491-502.
60. Hsu, L.Y.,
H.E. Liang, K. Johnson, C. Kang, and M.S. Schlissel. 2004. Pax5 activates
immunoglobulin heavy chain V to DJ rearrangement in transgenic thymocytes. J
Exp Med 199:825-830.
61. Liang,
H.E., L.Y. Hsu, D. Cado, and M.S. Schlissel. 2004.
Variegated transcriptional activation of the immunoglobulin kappa locus in
pre-b cells contributes to the allelic exclusion of light-chain expression. Cell
118:19-29.
62. Schlissel,
M. 2004. The spreading influence of chromatin modification.
Nat Genet 36:438-440.
63. Schlissel, M.S. 2004. Regulation of activation and recombination of the murine Igkappa locus. Immunol
Rev 200:215-223.
64. Amin, R.H., and M.S. Schlissel.
2005. NF-kappa B comes home. Immunity
22:401-402.
65. Curry,
J.D., J.K. Geier, and M.S. Schlissel. 2005. Single-strand recombination signal sequence nicks
in vivo: evidence for a capture model of synapsis. Nat
Immunol 6:1272-1279.
66. Curry,
J.D., L. Li, and M.S. Schlissel.
2005. Quantification of Jkappa signal end breaks in
developing B cells by blunt-end linker ligation and qPCR.
J Immunol Methods 296:19-30.
67. Geier, J.K., and M.S. Schlissel.
2005. Pre-BCR signals and the control of Ig gene rearrangements. Semin
Immunol
68. Tze, L.E., B.R. Schram, K.P. Lam,
K.A. Hogquist, K.L. Hippen,
J. Liu, S.A. Shinton, K.L. Otipoby, P.R. Rodine, A.L. Vegoe, M. Kraus,
R.R. Hardy, M.S. Schlissel, K.
Rajewsky, and T.W. Behrens. 2005. Basal immunoglobulin signaling actively
maintains developmental stage in immature B cells. PLoS Biol 3:e82.
69. Geier, J.K., and M.S. Schlissel.
2006. Pre-BCR signals and the control of Ig gene rearrangements. Semin Immunol
18:31-39.
70. Huang, F.,
Y. Kitaura, I. Jang, M. Naramura,
H.H. Kole, L. Liu, H. Qin, M.S. Schlissel, and H. Gu. 2006. Establishment of the major
compatibility complex-dependent development of CD4+ and CD8+ T cells by the Cbl family proteins. Immunity
25:571-581.
71. Lazorchak, A.S., M.S. Schlissel,
and Y. Zhuang. 2006. E2A and IRF-4/Pip promote chromatin modification and
transcription of the immunoglobulin kappa locus in pre-B cells. Mol
Cell Biol 26:810-821.
72. Pedraza-Alva, G., M. Koulnis, C. Charland, T. Thornton, J.L. Clements, M.S. Schlissel, and M. Rincon. 2006.
Activation of p38 MAP kinase by DNA double-strand breaks in V(D)J
recombination induces a G2/M cell cycle checkpoint. Embo
J 25:763-773.
73. Schlissel, M.S., C.R. Kaffer, and J.D. Curry. 2006. Leukemia and lymphoma: a cost
of doing business for adaptive immunity. Genes Dev
20:1539-1544.
74. Schlissel, M.S., and T.C. Kuo. 2006. AID for innate immunity to retroviral
transformation. Immunity
24:671-672.
75. Bates,
J.G., D. Cado, H. Nolla,
and M.S. Schlissel. 2007.
Chromosomal position of a VH gene segment determines its activation and
inactivation as a substrate for V(D)J recombination. J
Exp Med 204:3247-3256.
76. Curry,
J.D., D. Schulz, C.J. Guidos, J.S. Danska, L. Nutter, A. Nussenzweig, and M.S. Schlissel. 2007. Chromosomal
reinsertion of broken RSS ends during T cell development. J
Exp Med 204:2293-2303.
77. Kitaura, Y., I.K. Jang, Y. Wang, Y.C. Han, T. Inazu, E.J. Cadera, M. Schlissel, R.R. Hardy, and H. Gu. 2007.
Control of the B cell-intrinsic tolerance programs by ubiquitin
ligases Cbl and Cbl-b. Immunity
26:567-578.
78. Schlissel, M.S. 2007. The regulation of receptor editing. Adv
Exp Med Biol 596:173-179.
79. Amin, R.H., and M.S. Schlissel.
2008. Foxo1 directly regulates the transcription of recombination-activating
genes during B cell development. Nat Immunol
9:613-622.
80. Curry,
J.D., and M.S. Schlissel. 2008.
RAG2's non-core domain contributes to the ordered regulation of V(D)J recombination. Nucleic Acids
Res 36:5750-5762.
81. Hewitt,
S.L., D. Farmer, K. Marszalek, E. Cadera,
H.E. Liang, Y. Xu, M.S. Schlissel,
and J.A. Skok. 2008. Association between the Igk and Igh immunoglobulin loci mediated by the 3' Igk enhancer
induces 'decontraction' of the Igh
locus in pre-B cells. Nat Immunol
9:396-404.
82. Amin, R.H., D. Cado, H. Nolla, D. Huang, S.A. Shinton, Y. Zhou, R.R. Hardy, and M.S.
2009. Biallelic, ubiquitous transcription from the
distal germline Ig{kappa} locus promoter during B cell
development. Proc Natl Acad
Sci U S A 106:522-527.